Dr. Groves is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
901 W 38th St Ste 200
Austin, TX 78705Phone+1 512-421-4100Fax+1 512-454-4575- Is this information wrong?
Education & Training
University of Texas M D Anderson Cancer CenterFellowship, Neuro-Oncology, 1996 - 1998
University of Texas Health Science Center at HoustonResidency, Neurology, 1993 - 1996- University of Texas Health Science Center at HoustonInternship, Transitional Year, 1992 - 1993
Baylor College of MedicineInternship, Transitional Year, 1986 - 1987- Baylor College of MedicineClass of 1986
Certifications & Licensure
TX State Medical License 1987 - 2020
Clinical Trials
- Temozolomide Plus Thalidomide in Treating Patients With Recurrent or Progressive Brain Tumor Start of enrollment: 2000 Jun 13
- Capecitabine and Pegylated Interferon Alfa-2a in Treating Patients With Recurrent or Progressive Brain Metastases Due to Breast Cancer Start of enrollment: 2005 Sep 01
- Dietary Methionine Restriction Plus Temozolomide for Recurrent GBM Start of enrollment: 2004 Aug 01
- Join now to see all
Publications & Presentations
PubMed
- 37 citationsOncolytic DNX-2401 virotherapy plus pembrolizumab in recurrent glioblastoma: a phase 1/2 trial.Farshad Nassiri, Vikas Patil, Leeor S Yefet, Olivia Singh, Jeff Liu, Rachel M A Dang, Takafumi N Yamaguchi, Mariza Daras, Timothy F Cloughesy, Howard Colman, Priya U K...> ;Nature Medicine. 2023 Jun 1
- 22 citationsA phase I/II study of intrathecal trastuzumab in human epidermal growth factor receptor 2-positive (HER2-positive) cancer with leptomeningeal metastases: Safety, effic...Priya U Kumthekar, Michael J Avram, Andrew B Lassman, Nancy U Lin, Eudocia Lee, Sean A Grimm, Margaret Schwartz, Kirsten L Bell Burdett, Rimas V Lukas, Karan Dixit, Is...> ;Neuro-Oncology. 2023 Mar 14
- 13 citationsBintrafusp alfa (M7824), a bifunctional fusion protein targeting TGF-β and PD-L1: results from a phase I expansion cohort in patients with recurrent glioblastoma.Mustafa Khasraw, Michael Weller, David Lorente, Kathryn Kolibaba, Chee Khoon Lee, Craig Gedye, Macarena I. de la Fuente, David Vicente, David A. Reardon, Hui K Gan, An...> ;Neuro-Oncology Advances. 2021 Jan 1
- Join now to see all
Press Mentions
Brain Cancer Research Takes the Lead with Head for the Cure 5KApril 26th, 2019
Hospital Affiliations
University of Texas M.D. Anderson Cancer CenterHouston, Texas
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
